@article{1056688f36bb426d9fd7df9de2e60e80,
title = "Microenvironment-Mediated Resistance to Anti-Androgen Therapy",
abstract = "In this issue of Cancer Cell, Zhang et al. expose new possibilities for targeting castration-resistant prostate cancer (CRPC). Activation of the HER2/HER3 axis by cancer-associated fibroblast-secreted NRG1 mediates castration resistance, recommending novel applications of clinical anti-NRG1/HER3 therapeutics in treating CRPC.",
author = "Orme, {Jacob J.} and Haojie Huang",
note = "Funding Information: The analyses shown here are in part based upon data acquired from ClinicalTrials.gov through the Clinical Trials Transformation Initiative ( https://www.ctti-clinicaltrials.org/ ). J.J.O. and H.H. are funded by NIH ( CA231541 to J.J.O. and CA134514 , CA130908 , CA193239 , and CA203849 to H.H.) Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",
year = "2020",
month = aug,
day = "10",
doi = "10.1016/j.ccell.2020.07.007",
language = "English (US)",
volume = "38",
pages = "155--157",
journal = "Cancer cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",
}